Disclosure of Statement of deviation or Variation for the half-year and financial year ended March 31, 2026, pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosures Requirements) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valencia Nutrition Ltd has submitted a compliance filing confirming that all funds raised through three separate capital issuances have been fully utilized with zero deviation from stated objects. The company raised Rs. 17.07 crore through preferential issue of equity shares and convertible warrants (January 2025), Rs. 1.35 crore through a second preferential equity issue (November 2025), and Rs. 3.27 crore through warrant conversion equity shares (February 2026). Total funds of Rs. 21.69 crore were deployed across manufacturing unit setup, new product development and marketing, an online platform, working capital, and general corporate purposes. Statutory auditors HAY and Associates LLP certified full utilization with NIL deviation or variation for all three issuances.
Positive signal for shareholders as the company has demonstrated disciplined use of capital raised via preferential issues, with full deployment confirmed by auditors and audit committee review. No red flags around fund diversion or non-compliance.